Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer

1. Arriola, E.
2. de Castro, J.
3. García-Campelo, R.
4. Bernárdez, B.
5. Bernabé, R.
6. Bruna, J.
7. Dómine, M.
8. Isla, D.
9. Juan-Vidal, Ó.
10. López-Fernández, T.
11. Nadal, E.
12. Rodríguez-Abreu, D.
13. Vares, M.
14. Asensio, Ú.
15. García, L.F.
16. Felip, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/S40261-024-01379-7 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus